AstraZeneca CEO Talks Drug Sales in US
Bloomberg Talks
00:00
Strengthening U.S. Pharmaceutical Manufacturing
This chapter examines the effects of presidential policies on the pharmaceutical manufacturing sector in the U.S., detailing a $50 billion commitment to enhance domestic production. It also highlights the strategic importance of states like Virginia and North Carolina in supporting industry growth and maintaining leadership in biosciences.
Transcript
Play full episode
